Quick Summary
Goat’s Rue (Galega officinalis) is a traditional plant historically associated with the discovery of antidiabetic biguanides, particularly metformin, a widely used synthetic drug for managing type 2 diabetes. While the herb itself remains under research, metformin—derived from bioactive metabolites of Galega officinalis—has extensive clinical evidence supporting its use in diabetes and other health conditions. However, clinical evidence directly supporting therapeutic use of the herb is limited, and more high-quality human studies are needed.
What Is It?
Galega officinalis, commonly known as Goat’s Rue, is a perennial herb native to parts of Europe and Western Asia. Its historical significance stems mainly from its constituents that led to the development of metformin, a standard prescription medication for diabetes. The plant has been used traditionally for various purposes, but modern research into its direct benefits and safety in humans is still evolving.
Traditional Uses
Traditionally, Goat’s Rue has been used as an herbal remedy for managing blood sugar levels and as a galactagogue to potentially enhance milk production in breastfeeding mothers. Its longstanding use in folk medicine set the foundation for investigating its chemical compounds and therapeutic potential.
Active Compounds
The herb contains bioactive metabolites from which metformin, a synthetic biguanide antidiabetic agent, was developed. Exact constituents of Goat’s Rue responsible for its traditional effects include guanidine derivatives and related compounds, although detailed phytochemical profiles require further study.
Potential Benefits with Evidence Levels
- Antidiabetic effects: Preclinical and historical evidence suggests the herb’s bioactive compounds contributed to development of metformin. Metformin itself has strong clinical trial support for managing type 2 diabetes mellitus. However, direct clinical evidence for Galega officinalis alone is limited.
- Potential galactagogue effect: Low certainty evidence from small randomized controlled trials on herbal mixtures containing Goat’s Rue indicate possible increases in milk volume among breastfeeding mothers, particularly of preterm infants. Larger, well-controlled clinical trials are lacking.
Side Effects
There is insufficient human data on side effects directly attributable to Galega officinalis. Metformin, a derivative compound, is generally safe but can cause gastrointestinal symptoms such as nausea and diarrhea, and with prolonged use may contribute to vitamin B12 deficiency. Animal studies have reported toxicity of Goat’s Rue, especially in livestock such as sheep. Minor, transient complaints have been noted in galactagogue studies involving herbal mixtures containing the plant.
Drug Interactions
No specific drug interaction data exist for Galega officinalis. Metformin interacts with medications that affect kidney function and vitamin B12 absorption, particularly acid-suppressing drugs. Caution is advised when combining such agents, but human interaction studies with the herb itself are unavailable.
Who Should Avoid It?
There are no established contraindications specifically for Goat’s Rue. However, given associations with metformin, caution should be exercised in individuals with severe kidney impairment, certain metabolic disorders, or acute illness. Due to limited safety data, pregnant and breastfeeding women, and those with underlying health conditions should consult healthcare professionals before using the herb or related supplements.
Evidence Limitations
High-quality human clinical trials directly evaluating Galega officinalis monotherapy for efficacy and safety are lacking. Most clinical data pertain to metformin, a synthetic compound inspired by metabolites of the herb. Clinical studies investigating galactagogue effects of herbal mixtures containing Goat’s Rue are limited by small sample sizes, heterogeneity, low certainty, and incomplete safety reporting. Traditional and preclinical data require validation through rigorous human research.
References
- Cragg A, Levene I, Darabi S, Willcox M. Herbal galactagogues to improve breastmilk production and lactation in mothers of preterm babies: a systematic review of clinical trials. (2026)
– Suggests low certainty evidence that mixtures including Galega officinalis may increase milk volume; however, trials are small and heterogeneous. - Froldi G. View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences. (2024)
– Comprehensive review of metformin’s efficacy, mechanisms, pharmacokinetics, and safety profile. - Vivó-Barrachina L et al. The Role of Natural Products on Diabetes Mellitus Treatment: A Systematic Review of Randomized Controlled Trials. (2022)
– Concludes insufficient human clinical evidence to support treatment based solely on herbal products including Galega officinalis. - Antidiabetic activity of medicinal galega (Galega officinalis L.) (1994)
– Early scientific evidence forming a basis for metformin development; limited direct clinical data. - Bazzano AN et al. A Review of Herbal and Pharmaceutical Galactagogues for Breast-Feeding. (2016)
– Review highlighting lack of high-quality trials and mixed efficacy and safety results of herbal galactagogues. - Galega officinalis (goatsrue) (2017)
– Reports on animal toxicity and traditional uses; calls for formal toxicological profiling for human safety.
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not medical advice. Always consult a healthcare provider before using herbal supplements, especially if you have existing health conditions, are pregnant, breastfeeding, or taking medications.